Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404452 · ClinicalTrials.gov registry record
Heart Failure Monitoring With Eko Electronic Stethoscopes
A clinical trial, sponsored by Eko Devices.
- Terminated
- Registry status
- 15
- Enrollment target
NCT04404452: Clinical Trial study, sponsored by Eko Devices.
NCT04404452 is a clinical trial that was terminated before completion, run by Eko Devices. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04404452 was terminated before completion, sponsored by Eko Devices.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This proof-of-concept study will evaluate the feasibility of the Eko DUO to measure signals relevant to heart failure (HF) decompensation, as well as the feasibility to develop an algorithm to model hemodynamic filling pressures in HF patients under active decompensation in a cardiac intensive care unit (CICU) or coronary care unit (CCU). To also assess the performance of the Eko CORE to detect signals of an HF event, this study will also take heart and lung sound measurements with the Eko CORE.
Primary Outcome
Assess the feasibility of use of the Eko DUO, a non-invasive cutaneous device with simultaneous ECG and PCG recording, on ADHF patients in an CICU/CCU setting based on ease of protocol compliance.
Interventions
- DEVICE Use of Eko CORE and Eko DUO electronic stethoscopes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-07-06 |
| Est. Completion | 2020-12-14 |
Why NCT04404452 stopped before completion
NCT04404452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko CORE and Eko DUO electronic stethoscopes is the first listed.
NCT04404452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04404452 about?
NCT04404452 is a clinical study titled "Heart Failure Monitoring With Eko Electronic Stethoscopes". This proof-of-concept study will evaluate the feasibility of the Eko DUO to measure signals relevant to heart failure (HF) decompensation, as well as the feasibility to develop an algorithm to model hemodynamic filling pressures in HF patients under active decompensation in a cardiac intensive care ...
What is the current status of trial NCT04404452?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2020-07-06. Estimated completion is 2020-12-14.
What interventions are being tested in trial NCT04404452?
The interventions under investigation include: Use of Eko CORE and Eko DUO electronic stethoscopes (DEVICE).
Who is sponsoring clinical trial NCT04404452?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI